Capecitabine

• Supplier: Tocris Bioscience
• Catalog: 1548
• Prices: $139.00
• Sizes: 50 mg
• Cas Number: 154361-50-9
• Chemical Name: 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine
• Formula: C15H22FN3O6
• Molecular Weight: 359.35
• Purity: >98 %
• Description: Prodrug of 5-Fluorouracil (5-FU) (Cat. No. 3257). Selectively activated in tumor cells by thymidine phosphorylase; inhibits DNA synthesis upon conversion to 5-FU. Orally available.

Product References

Cell cycle phase specificity of antitumor agents. - Cell cycle phase specificity of antitumor agents.

Bhuyan BK, Scheidt LG, Fraser TJ. Cancer Res. 1972 Feb;32(2):398-407.

The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, - The design and synthesis of a new tumor-selective fluoropyrimidine carbamate,

Shimma N, Umeda I, Arasaki M, Murasaki C, Masubuchi K, Kohchi Y, Miwa M, Ura M, Sawada N, Tahara H, Kuruma I, Horii I, Ishitsuka H. Bioorg Med Chem. 2000 Jul;8(7):1697-706.

Metabolism of capecitabine, an oral fluorouracil prodrug: (19)F NMR studies in - Metabolism of capecitabine, an oral fluorouracil prodrug: (19)F NMR studies in

Desmoulin F, Gilard V, Malet-Martino M, Martino R. Drug Metab Dispos. 2002 Nov;30(11):1221-9.